{"url_path":"/sec/neo/8-k/2026-07-20/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-20","source_url":"https://www.sec.gov/Archives/edgar/data/1077183/0001077183-26-000045-index.html","accession_number":"0001077183-26-000045","cik":"0001077183","ticker":"NEO","issuer_name":"NEOGENOMICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1077183/0001077183-26-000045-index.html","primary_entity_key":"0001077183","primary_entity_name":"NEOGENOMICS INC"},"word_count":89,"has_tables":true,"body_markdown":"Item 9.01\nFinancial Statements and Exhibits.\n\n(a)\n\nNot applicable\n\n(b)\n\nNot applicable\n\n(c)\n\nNot applicable\n\n(d)\n\nExhibits.\n\n[99.1](a2026-07x20pressrelease.htm)\n\n[Press Release of NeoGenomics, Inc. dated July 20, 2026](a2026-07x20pressrelease.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nNEOGENOMICS, INC.\n\nDate: July 20, 2026By:/s/ Alicia C. Olivo\n\nName:Alicia C. Olivo\n\nTitle:Executive Vice President, General Counsel & Secretary"}